Eitan Rotem
Managing Partner at Nox Family office
Herzliya, Tel Aviv District
Eitan Rotem, Managing Partner at Nox Family office is an active investor based in Herzliya, Tel Aviv District. This profile covers what Eitan Rotem backs, at which stage, and how founders can reach out in 2026.
- Investor type
- Family Office
- Stages
- SeedSeries A
- Invests in
- FintechWealthTech
- Location
- Herzliya, Tel Aviv District
- Typical check
- $625K
How to reach Eitan Rotem
Angels and operators like Eitan Rotem reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Eitan Rotem
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Eitan Rotem invest in?
Eitan Rotem invests in Fintech and WealthTech, typically at Seed and Series A. Match your sector and stage, then reach out with a personalized pitch.
What stage does Eitan Rotem invest at?
Eitan Rotem typically invests at Seed and Series A. Lead with traction that fits the stage when you reach out.
What is Eitan Rotem's typical check size?
Eitan Rotem typically writes checks around $625K. Use it as a signal for whether your raise fits their stage.
How do I contact Eitan Rotem?
Unlock Eitan Rotem's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.